Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Cons Longevity
Retatrutide (LY-3437943) is an investigational triple agonist activating: GLP-1 receptors GIP receptors Glucagon receptors This triple-pathway mechanism has produced some of the largest average weight-loss outcomes reported in obesity trials , positioning retatrutide as one of the most potent investigational metabolic agents to date
The authors described it as the first selective GHRP-receptor agonist. Reported in animal pharmacology models
Long-Term Skin Health Support: Its gene-modulating properties suggest a potential for supporting overall skin vitality and resilience over time, beyond just addressing immediate concerns
Increased prominence of fibrosis, which may surround hepatic lobules and bridge between adjacent portal areas
Upon receipt, inspect the vial visually per the criteria above and store immediately at the recommended temperature
